PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/3735/2/23
Off-label Promotion Not Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
Health professional complaint about Lilly representative visits to dermatology department (No breach
A health professional complained about the activities of a named Eli Lilly sales representative visiting a busy dermatology department.The complainant alleged the representative had been told on nu…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3747/2/23
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka UK
An anonymous complainant challenged a LinkedIn post made by Otsuka US about ulotaront (SEP-363859/SEP-363856) for adjunctive treatment of major depressive disorder (MDD), calling it promotion of an…
Clauses: 9.1,9.2
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3763/4/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
Two academic complainants raised concerns about Novo Nordisk’s Disclosure UK reporting and third-party activities linked to a training provider and a pharmacy services provider. Transfers of valu…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3749/3/23
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
AGB-Pharma
A complainant reported a website that appeared to advertise a UK prescription-only medicine (Adaflex) without restriction and freely accessible to the public.The Adaflex branded webpage included a …
Clauses: 9.1,4.1
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3758/4/23
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
ALK-Abelló
An anonymous, non-contactable complainant alleged an ALK-Abelló representative posted about the prescription only medicine (POM) Jext (adrenaline tartrate) on Facebook and asked friends to share i…
Clauses: 9.1,9.2
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3773/6/23
Social Media & Digital Not Upheld 🏥 Immunology & Rheumatology ▶ Video 🎙 Podcast
Astellas
An anonymous, non-contactable complainant (described as a pharmaceutical company employee) complained about an Astellas LinkedIn post advertising a company-organised presentation at UK Kidney Week …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3762/4/23
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
SyriMed
An ex-employee alleged a named employee had been marketing/promoting branded medicines to GPs, pharmacists and hospital clinicians for more than two years without the requisite representative quali…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3753/3/23
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Novavax
A complainant said that after clicking a Google link they were shown an advert for Nuvaxovid (a COVID-19 vaccine) on the P3 Pharmacy website without being asked to confirm they were a healthcare pr…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3769/5/23
Social Media & Digital Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca breached an undertaking after repeat missing prescribing information on Trixeo website (
A complaint (also taken up by the Director) alleged a breach of undertaking linked to the Trixeo promotional website.In an earlier case (AUTH/3488/3/21, 2019 Code), AstraZeneca was found in breach …
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3760/4/23
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
GSK press release on COVID-19 vaccine efficacy ruled misleading (RRR presented without sufficient co
A member of the public complained about a GSK press release on its corporate website about Sanofi and GSK’s COVID-19 booster vaccine VidPrevtyn Beta.The press release stated: “The results showe…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3796/7/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca breached Clause 3.1 after UK employee ‘liked’ third-party LinkedIn post about phase 3 da
A complaint alleged AstraZeneca was promoting an off-licence/unlicensed medicine (datopotamab deruxtecan) to the public on LinkedIn after an AstraZeneca UK employee ‘liked’ a third-party post a…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3827/9/23
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Roche
An anonymous, non-contactable complainant (self-described health professional) complained about a Roche promotional webpage about Ocrevus infusion schedules. The complainant alleged the graphic was…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3798/7/23
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Bausch & Lomb voluntary admission after former agency LinkedIn post referenced Emerade (No breach)
Bausch & Lomb made a voluntary admission after discovering a LinkedIn post by a creative agency it had previously used, but was not currently under contract with.The agency’s post included th…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3794/7/23
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Merck Serono fertility event
An anonymous, non-contactable complainant (describing themselves as a fertility specialist) complained about a Merck Serono fertility educational meeting in London attended by ~60 HCPs.The complain…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3793/7/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant alleged two articles on a charitable organisation’s website were disease awareness pieces funded by Daiichi Sankyo, with sponsorship only apparent at the end of the artic…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3765/4/23
Social Media & Digital Not Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Takeda Rare Disease Hub website
An anonymous, contactable UK health professional complained about Takeda’s “Rare Disease Hub” website (certified as promotional and gated for UK HCPs via attestation).Concerns included: a bla…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3784/6/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
A third party posted on LinkedIn naming four AstraZeneca oncology medicines: Tagrisso, Lynparza, Enhertu and Calquence.The post included efficacy messaging (eg Tagrisso trial data “cut the risk o…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3821/9/23
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An anonymous health professional complained about Saxenda (liraglutide 3mg) in the context of GLP-1 supply shortages and alleged Novo Nordisk continued to promote Saxenda despite supply issues.The …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3800/7/23
HCP Hospitality & Meetings Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Employee complaint alleging MEGS used to promote Imfinzi (No breach)
An AstraZeneca employee complained that during Oct 2020 (COVID-19 period) AstraZeneca Oncology used a Medical and Educational Goods and Services (MEGS) programme (“Auxilium CRT”) to promote Imf…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3865/12/23
HCP Hospitality & Meetings Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
An ex-employee complained about a Novo Nordisk promotional meeting for Wegovy held in Scotland on 04–05 November 2022.The complainant alleged Wegovy did not have a marketing authorisation (MA) in…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3746/2/23
HCP Hospitality & Meetings Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Moderna
A named complainant (member of the public) alleged that a Moderna session at ECCMID (Lisbon, 24 April 2022) was effectively a “Product Theatre” promoting Spikevax and included off-label booster…
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3751/3/23
Social Media & Digital Upheld 🏥 Rare Diseases ▶ Video 🎙 Podcast
Otsuka
An ex-employee complained about the Jinarc (tolvaptan) UK training portal wording, saying it implied HCPs must register details to be eligible to prescribe, while also stating enrolment was “not …
Clauses: 9.1,7.2
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3771/6/23
Off-label Promotion Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
Complainant v GSK
An anonymous, contactable complainant (described as a health professional; later became non-contactable) complained about a GSK Pro promotional webpage for Trelegy Ellipta.The page included a NICE …
Clauses: NONE
2023 🔒 Subscribe
🔒 Subscribers only
AUTH/3772/6/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
A contactable complainant challenged a promotional email for Nustendi (bempedoic acid + ezetimibe) sent via a third-party publisher. The email prominently urged: “Switch ezetimibe to Nustendi to …
Clauses: NONE
2023 🔒 Subscribe
← Prev 1 2 3 4 5 6 7 Next → Page 4 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews